Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket, is thought to reduce proinflammatory molecules and even increase production of anti-inflammatory species in MS patients. But researchers now report that the molecule reduces the binding of three components -- zinc, C-peptide and albumin -- to red blood cells.
from Top Health News -- ScienceDaily https://ift.tt/8ziKcIu
No comments:
Post a Comment